Intravenous Thrombolytic Therapy for Treatment of Acute Ischemic Stroke in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants

JAMA. 2022 Feb 22;327(8):725-726. doi: 10.1001/jama.2022.0068.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Ischemic Stroke*
  • Thrombolytic Therapy

Substances

  • Anticoagulants
  • Fibrinolytic Agents